A. Swart

Third generation anti-citrullinated peptide antibody assay is a sensitive marker in rheumatoid factor negative rheumatoid arthritis.

M. Mahler, A. Swart, R. Burlingame, 2012, Clinica chimica acta; international journal of clinical chemistry.

Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens.

M. Mahler, A. Swart, M. Benucci, 2013, Clinica chimica acta; international journal of clinical chemistry.

Compared to Patients with Systemic Autoimmune Rheumatic Diseases Anti-DFS 70 / LEDGF Antibodies Are More Prevalent in Healthy Individuals

M. Fritzler, M. Mahler, A. Swart, 2012 .

Anti-DFS70/LEDGF Antibodies Are More Prevalent in Healthy Individuals Compared to Patients with Systemic Autoimmune Rheumatic Diseases

M. Fritzler, M. Mahler, A. Swart, 2012, The Journal of Rheumatology.

Multi-center evaluation of autoantibodies to the major ribosomal P C22 epitope

Y. Shoenfeld, M. Fritzler, N. Agmon-Levin, 2012, Rheumatology International.

Clinical evaluation of a novel chemiluminescent immunoassay for the detection of anti-citrullinated peptide antibodies.

M. Mahler, A. Swart, I. Gürtler, 2014, Clinica chimica acta; international journal of clinical chemistry.

Rpp25 is a major target of autoantibodies to the Th/To complex as measured by a novel chemiluminescent assay

E. Chan, M. Fritzler, M. Mahler, 2013, Arthritis Research & Therapy.

Clinical and serological evaluation of a novel CENP-A peptide based ELISA

Rene Westhovens, Xavier Bossuyt, Michael Mahler, 2010, Arthritis research & therapy.

Clinical and serological associations of autoantibodies to the Ku70/Ku80 heterodimer determined by a novel chemiluminescent immunoassay

M. Fritzler, M. Mahler, A. Swart, 2016, Lupus.